# Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery

> **NCT03524339** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 132 (actual)

## Conditions studied

- Urinary Retention
- Lower Urinary Tract Symptoms
- Stress Urinary Incontinence
- Pelvic Organ Prolapse

## Interventions

- **DRUG:** Placebo oral capsule
- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT03524339
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2020-06-09
- **Final completion:** 2020-06-09
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2021-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03524339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03524339, "Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03524339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*